Eli Lilly to launch disposable insulin pens in March ’03
THIS winter has been action packed for the domestic insulin market. To add to the fervour Eli Lilly India is set to launch its disposable human insulin pen in the country in March this year.

Ranbaxy to explore herbals
Aiming to become a leading player in the herbal segment, Ranbaxy is all set to market herbal drugs according to company officials.

BD to develop Indian arm as mfg hub for China & SE Asia
BECTON Dickinson, US-based $4 billion medical devices major, is looking at developing its Indian subsidiary a sourcing hub for South-East Asia.

Juggat Pharma plans foray into Brazilian market
JUGGAT Pharma, the flagship pharmaceutical division of the Bangalore based Jagdale Industries Ltd (JIL) plans to make a foray into the Brazilian market in the next six months.

India will not agree to dilution of Doha agenda: Jaitley
Commerce minister Arun Jaitley has made it clear that India will not agree to any dilution of the Doha development agenda, says a PIB release.

Lupin sets up facility to mfr lovastatin
In a move to consolidate its presence in the lifestyle drug segment, Lupin Limited is setting up a new plant for manufacturing lovastatin, a cholesterol lowering active pharmaceutical ingredient (API).

Caraco expects 56 pc jump in ’03 revenues
THE Detroit-based, Caraco Pharmaceutical Laboratories, Ltd 2003 revenues are expected to jump 56 per cent to $35 million, from 2002’s revenues of $22.4 million, informed Narendra N Borkar, chief-executive-officer.

Surya launches X-Diaba for diabetics
SURYA Herbal Limited, the first Ayurvedic ISO 9001 certified Company, has launched X-Diaba, a Herbomineral approach that can slow, stop and even cure diabetes, states a press release.